Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Receives Average Recommendation of “Hold” from Brokerages
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has received a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price […]
More Stories
National Bankshares Has Lowered Expectations for Arizona Metals (CVE:AMC) Stock Price
Arizona Metals (CVE:AMC – Free Report) had its price target trimmed by National Bankshares from C$4.00 to C$3.75 in a...
Medallion Financial (NASDAQ:MFIN) Cut to Hold at StockNews.com
StockNews.com downgraded shares of Medallion Financial (NASDAQ:MFIN – Free Report) from a buy rating to a hold rating in a...
StockNews.com Upgrades Devon Energy (NYSE:DVN) to “Hold”
Devon Energy (NYSE:DVN – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in...
RADCOM (NASDAQ:RDCM) Cut to “Buy” at StockNews.com
StockNews.com cut shares of RADCOM (NASDAQ:RDCM – Free Report) from a strong-buy rating to a buy rating in a research...
StockNews.com Begins Coverage on Xcel Brands (NASDAQ:XELB)
Research analysts at StockNews.com started coverage on shares of Xcel Brands (NASDAQ:XELB – Get Free Report) in a report released...
StockNews.com Begins Coverage on Lifeway Foods (NASDAQ:LWAY)
StockNews.com started coverage on shares of Lifeway Foods (NASDAQ:LWAY – Free Report) in a research report report published on Tuesday...